drugset / Trial / NCT04202289

Use of Nile Tilapia Fish Skin as a Xenograft for Burn Treatment: Phase III Study

NCT04202289

RandomizedParallel-groupOpen-labelTreatment

Summary

The present study is a Phase III Randomized Clinical Trial aiming to evaluate the efficacy of Nile tilapia (Oreochromis niloticus) skin as an occlusive biological dressing in the treatment of superficial partial-thickness burns in adults.

Timeline

Start
2017-04-03
Primary completion
2018-10-24
Completion
2018-10-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Silver Sulfadiazine Small molecule 1 % Topical

Indications

No indication recorded.